دورية أكاديمية
[Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results].
العنوان: | [Correction for: Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results]. |
---|---|
عنوان ترانسليتريتد: | Erratum für: Das klinische Ergebnis eines Therapiewechsels von Ranibizumab und/oder Bevacizumab zu Aflibercept bei neovaskulärer altersabhängiger Makuladegeneration (AMD). |
المؤلفون: | Pfau M; Augenklinik, Universitätsklinikum Bonn., Fassnacht-Riederle HM; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Freiberg FJ; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Wons JB; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Wirth M; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Becker MD; Augenklinik, Stadtspital Triemli, Zürich, Schweiz., Michels S; Augenklinik, Stadtspital Triemli, Zürich, Schweiz. |
المصدر: | Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2016 Aug; Vol. 233 (8), pp. e3. Date of Electronic Publication: 2016 Sep 06. |
نوع المنشور: | Journal Article; Published Erratum |
اللغة: | German |
بيانات الدورية: | Publisher: Thieme Country of Publication: Germany NLM ID: 0014133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-3999 (Electronic) Linking ISSN: 00232165 NLM ISO Abbreviation: Klin Monbl Augenheilkd Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: Stuttgart : Thieme Original Publication: Stuttgart. |
التعليقات: | Erratum for: Klin Monbl Augenheilkd. 2016 Aug;233(8):945-50. (PMID: 27123887) |
تواريخ الأحداث: | Date Created: 20160907 Latest Revision: 20191120 |
رمز التحديث: | 20221213 |
DOI: | 10.1055/s-0042-115798 |
PMID: | 27599047 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1439-3999 |
---|---|
DOI: | 10.1055/s-0042-115798 |